Graphite Bio Inc. (GRPH) is priced at $12.80 after the most recent trading session. At the very opening of the session, the stock price was $14.01 and reached a high price of $14.08, prior to closing the session it reached the value of $13.86. The stock touched a low price of $12.70.Recently in News on October 12, 2021, Graphite Bio Presents Preclinical Data Supporting GPH101 in Sickle Cell Disease at 49th Annual Sickle Cell Disease Association of America National Convention. Data support ability of company’s gene editing platform to precisely and efficiently correct the underlying disease-causing mutation and restore adult hemoglobin expression with curative potential. You can read further details here
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Graphite Bio Inc. shares are logging -62.35% during the 52-week period from high price, and -0.23% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.83 and $34.00.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 510593 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Graphite Bio Inc. (GRPH) recorded performance in the market was -30.81%, having the revenues showcasing -48.39% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 838.66M, as it employees total of 49 workers.
Market experts do have their say about Graphite Bio Inc. (GRPH)
During the last month, 0 analysts gave the Graphite Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for GRPH is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Graphite Bio Inc. (GRPH)
Raw Stochastic average of Graphite Bio Inc. in the period of last 50 days is set at 0.94%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.29%. In the last 20 days, the company’s Stochastic %K was 11.69% and its Stochastic %D was recorded 14.06%.
Bearing in mind the latest performance of Graphite Bio Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -30.81%. The shares increased approximately by -8.70% in the 7-day charts and went up by -34.16% in the period of the last 30 days. Common stock shares were lifted by -48.39% during last recorded quarter.